314 related articles for article (PubMed ID: 30351407)
1. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study.
Savarese G; Dahlström U; Vasko P; Pitt B; Lund LH
Eur Heart J; 2018 Dec; 39(48):4257-4265. PubMed ID: 30351407
[TBL] [Abstract][Full Text] [Related]
2. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
3. Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study.
Edner M; Benson L; Dahlström U; Lund LH
Eur Heart J; 2015 Sep; 36(34):2318-26. PubMed ID: 26069212
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
Takeuchi S; Kohno T; Goda A; Shiraishi Y; Kitamura M; Nagatomo Y; Takei M; Nomoto M; Soejima K; Kohsaka S; Yoshikawa T;
Int J Cardiol; 2024 Aug; 409():132190. PubMed ID: 38761975
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Beta-blocker and Renin-Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients.
Gilstrap L; Solomon N; Chiswell K; James O'Malley A; Skinner JS; Fonarow GC; Bhatt DL; Yancy CW; Devore AD
J Card Fail; 2023 Apr; 29(4):434-444. PubMed ID: 36516937
[TBL] [Abstract][Full Text] [Related]
6. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.
Gayat E; Arrigo M; Littnerova S; Sato N; Parenica J; Ishihara S; Spinar J; Müller C; Harjola VP; Lassus J; Miró Ò; Maggioni AP; AlHabib KF; Choi DJ; Park JJ; Zhang Y; Zhang J; Januzzi JL; Kajimoto K; Cohen-Solal A; Mebazaa A;
Eur J Heart Fail; 2018 Feb; 20(2):345-354. PubMed ID: 28849606
[TBL] [Abstract][Full Text] [Related]
7. Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry.
Stolfo D; Uijl A; Benson L; Schrage B; Fudim M; Asselbergs FW; Koudstaal S; Sinagra G; Dahlström U; Rosano G; Savarese G
Eur J Heart Fail; 2020 Jan; 22(1):103-112. PubMed ID: 31478583
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
[TBL] [Abstract][Full Text] [Related]
9. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
10. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
12. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.
Beusekamp JC; Tromp J; van der Wal HH; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Rossignol P; Zannad F; Voors AA; van der Meer P
Eur J Heart Fail; 2018 May; 20(5):923-930. PubMed ID: 29327797
[TBL] [Abstract][Full Text] [Related]
13. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T
PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953
[TBL] [Abstract][Full Text] [Related]
14. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
[TBL] [Abstract][Full Text] [Related]
16. Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction.
Stolfo D; Lund LH; Sinagra G; Lindberg F; Dahlström U; Rosano G; Savarese G
Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):526-535. PubMed ID: 37204037
[TBL] [Abstract][Full Text] [Related]
17. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
Bangalore S; Fakheri R; Wandel S; Toklu B; Wandel J; Messerli FH
BMJ; 2017 Jan; 356():j4. PubMed ID: 28104622
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system inhibitors and clinical outcomes in patients with atrial fibrillation and heart failure: a propensity score-matched study from the Chinese Atrial Fibrillation Registry.
Lin J; He L; Qiao Q; Du X; Ma CS; Dong JZ
J Int Med Res; 2021 Sep; 49(9):3000605211041439. PubMed ID: 34521238
[TBL] [Abstract][Full Text] [Related]
20. Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.
Cappelletto C; Stolfo D; Orsini N; Benson L; Rodolico D; Rosano GMC; Dahlström U; Sinagra G; Lund LH; Savarese G
Eur J Heart Fail; 2023 May; 25(5):698-710. PubMed ID: 36781199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
